A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets

Bullous pemphigoid (BP) is a rare, chronic antibody-mediated autoimmune blistering disease primarily affecting the elderly, with an age of onset over 60. Current treatment options are limited and involve the use of corticosteroids and immunosuppressants, but their long-term use is associated with si...

Descripción completa

Detalles Bibliográficos
Autores principales: Afarideh, Mohsen, Borucki, Robert, Werth, Victoria P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146139/
https://www.ncbi.nlm.nih.gov/pubmed/35628982
http://dx.doi.org/10.3390/jcm11102856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146139/
https://www.ncbi.nlm.nih.gov/pubmed/35628982
http://dx.doi.org/10.3390/jcm11102856

Ejemplares similares